FMR LLC

Position in EQ — Equillium, Inc.

CIK 315066 BOSTON, MA

Position in EQ

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$720

+$434 QoQ

Shares Held

360

+80.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,690,752,415 across 354 Biotechnology names. EQ ranks #323 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$720	360	+80.0%	Shares	Defined	2026-05-15
2025-09-30	$286	200	+700.0%	Shares	Defined	2025-11-13
2023-06-30	$18	25	-99.8%	Shares	Defined	2023-08-11
2022-03-31	$32,331	10,264	-86.8%	Shares	Defined	2022-05-13
2021-12-31	$293,306	77,800	-62.9%	Shares	Defined	2022-02-14
2021-09-30	$1,430,836	209,800	0.0%	Shares	Defined	2022-02-14
2021-06-30	$1,235,722	209,800	0.0%	Shares	Defined	2021-08-13
2021-03-31	$1,500,070	209,800	0.0%	Shares	Defined	2021-05-14
2020-12-31	$1,122,430	209,800	0.0%	Shares	Defined	2021-02-08
2020-09-30	$1,210,546	209,800	-53.6%	Shares	Defined	2020-11-13
2020-06-30	$1,333,096	451,897	-27.1%	Shares	Defined	2020-08-24
2020-03-31	$1,679,774	619,843	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.